No black box warning on record for Glycerol Phenylbutyrate

As of the latest FDA labeling reviewed, Glycerol Phenylbutyrate (GLYCEROL PHENYLBUTYRATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Glycerol Phenylbutyrate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Neurotoxicity : Phenylacetate (PAA), the active moiety of glycerol phenylbutyrate, may be toxic; reduce dosage for symptoms of neurotoxicity. ( 5.1 ) Pancreatic Insufficiency or Intestinal Malabsorption: Monitor ammonia levels closely. ( 5.2 ) 5.1 Neurotoxicity Increased exposure to PAA, the major metabolite of glycerol phenylbutyrate, may be associated with neurotoxicit

No black box warning on record for Glycerol Phenylbutyrate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Neurotoxicity : Phenylacetate (PAA), the active moiety of glycerol phenylbutyrate, may be toxic; reduce dosage for symptoms of neurotoxicity. ( 5.1 ) Pancreatic Insufficiency or Intestinal Malabsorption: Monitor ammonia levels closely. ( 5.2 ) 5.1 Neurotoxicity Increased exposure to PAA, the major metabolite of glycerol phenylbutyrate, may be associated with neurotoxicit

Glycerol Phenylbutyrate Black Box Warning

No black box warning on record for Glycerol Phenylbutyrate

Other warnings & precautions

Glycerol Phenylbutyrate Black Box Warning

No black box warning on record for Glycerol Phenylbutyrate

Other warnings & precautions